Amgen Inc.
AMGN.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.26B | 35.49B | 35.15B | 34.50B | 33.51B |
| Total Other Revenue | 1.84B | 1.73B | 1.60B | 1.47B | 1.41B |
| Total Revenue | 38.10B | 37.22B | 36.75B | 35.97B | 34.92B |
| Cost of Revenue | 10.67B | 10.59B | 10.70B | 10.73B | 10.64B |
| Gross Profit | 27.43B | 26.63B | 26.05B | 25.24B | 24.28B |
| SG&A Expenses | 7.02B | 6.97B | 7.05B | 6.98B | 6.88B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 14.00M | -25.00M | 118.00M | 208.00M | 350.00M |
| Total Operating Expenses | 25.33B | 25.03B | 25.14B | 24.77B | 24.27B |
| Operating Income | 12.77B | 12.19B | 11.61B | 11.20B | 10.64B |
| Income Before Tax | 10.29B | 9.09B | 8.98B | 8.24B | 7.42B |
| Income Tax Expenses | 1.54B | 1.29B | 1.27B | 1.24B | 805.00M |
| Earnings from Continuing Operations | 8.74K | 7.80K | 7.71K | 7.01K | 6.62K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.74B | 7.80B | 7.71B | 7.01B | 6.62B |
| EBIT | 12.77B | 12.19B | 11.61B | 11.20B | 10.64B |
| EBITDA | 17.31B | 16.96B | 16.66B | 16.52B | 16.05B |
| EPS Basic | 16.22 | 14.48 | 14.33 | 13.02 | 12.31 |
| Normalized Basic EPS | 12.35 | 11.56 | 10.35 | 9.67 | 8.89 |
| EPS Diluted | 16.10 | 14.38 | 14.24 | 12.94 | 12.23 |
| Normalized Diluted EPS | 12.26 | 11.48 | 10.28 | 9.61 | 8.82 |
| Average Basic Shares Outstanding | 2.16B | 2.16B | 2.15B | 2.15B | 2.15B |
| Average Diluted Shares Outstanding | 2.17B | 2.17B | 2.17B | 2.17B | 2.17B |
| Dividend Per Share | 9.80 | 9.66 | 9.52 | 9.39 | 9.26 |
| Payout Ratio | 60.45% | 66.71% | 66.45% | 72.03% | 75.15% |